Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

NCT ID: NCT05545995

Last Updated: 2022-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-31

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective randomised study of the evaluation of the clinical IVF results after time lapse assisted embryo selection versus Non-invasive PGT-A assisted embryo selection in subfertile women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized prospective study focusing on subfertile women undergoing IVF treatment followed by embryo transfer on the blastocyst stage.

Women assigned to group A proceed to embryo transfer, after time lapse assisted embryo selection, while women of group B after non-invasive PGT-A assisted embryo selection.

IVF outcomes, regarding the success rate of the trasnfer and the time required to achieve conception is studied in both groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility Aneuploidy Chromosome Abnormality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TIME LAPSE

Women who proceed to embryo transfer after time lapse assisted embryo selection.

embryo selection

Intervention Type OTHER

The basis of embryo seletion for transfer: morphological or genetic after non-invasive PGT-A

NI-PGT-A

Women who proceed to embryo transfer after non-invasive PGT-A assisted embryo selection.

embryo selection

Intervention Type OTHER

The basis of embryo seletion for transfer: morphological or genetic after non-invasive PGT-A

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

embryo selection

The basis of embryo seletion for transfer: morphological or genetic after non-invasive PGT-A

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who followed IVF treatment
* 39 years old or younger
* Single embryo transfer
* blastocyst stage cultured embryos

Exclusion Criteria

* women over the age of 39 years
* not blastocyst transfer (transfers performed at earlier embryo stage)
* double embryotransfer
* women who had invasive PGT-a test
* women whose embryos were not time-lapse monitored
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assisting Nature

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Papanikolaou Evaggelos

Papanikolaou Evaggelos, MD, PhD, Fertility Specialist, Scientific Director at Assisting Nature IVF Clinic

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Evangelos Papanikolaou, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

Assisting Nature

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assisting Nature

Thessaloniki, , Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Evangelos Papanikolaou, MD,PhD

Role: CONTACT

00302310424294

Maria Galiotou, MSc

Role: CONTACT

00302310424294

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Evaggelos Papanikolaou, MD, PhD

Role: primary

00302310424294

Maria Galiotou, MSc

Role: backup

00302310424294

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AN009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prediction of Ovarian Response
NCT00557687 COMPLETED